Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$121.3M
-88.2% from 2023
Prescriptions
559K
$216.83 per claim
Patients
211K
113,491 prescribers
Total spending, 2024
$121.3M
$575.41 per patient
Medicare prescription drug plans paid $121.3M for Levemir Flexpen in 2024, for 559,280 prescriptions and refills to 210,723 patients (down 88.2% from 2023). The average cost per claim was $216.83.
Texas had the highest Medicare cost for Levemir Flexpen in 2024: $13.6M for 57,981 claims, followed by Florida ($9.5M).
Maher Alesali, endocrinology in White Hall, AR, had the highest Medicare cost for Levemir Flexpen in 2024: 142 claims costing $36K.
Levemir Flexpen is made by Novo Nordisk A/S (NVO), listed in the Medicare spending data as Novo Nordisk.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Maher Alesali White Hall, AR | Endocrinology | 142 | 40 | $36K |
| Mohamed F Zeitoun Hobart, IN | Endocrinology | 91 | 46 | $35K |
| Vishal Bhatia Evansville, IN |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2023 | 155,356 | 1,370,081 | 346,051 | $1.03B |
| 2024 | 113,491 | 559,280 | 210,723 | $121.3M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims |
|---|
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Endocrinology |
| 125 |
| 62 |
| $35K |
| David J Ohotnicky Torrington, CT | Nurse Practitioner | 78 | 33 | $32K |
| Hemlata Moturi Pittsburgh, PA | Endocrinology | 101 | 43 | $31K |
| Najmuddin K Karimjee Houston, TX | Internal Medicine | 115 | 50 | $30K |
| Kristyl J Woolsey Little Rock, AR | Nurse Practitioner | 74 | 24 | $29K |
| Sarvesh Rajan Du Bois, PA | Endocrinology | 68 | 32 | $29K |
| Mohammad N Al Shroof Warner Robins, GA | Internal Medicine | 162 | 45 | $27K |
| Van S Breeding Whitesburg, KY | Family Practice | 81 | 31 | $27K |
| Saba Khayal Memphis, TN | Endocrinology | 82 | 37 | $26K |
| Douglas G Gresham Savannah, GA | Endocrinology | 63 | 33 | $26K |
| Hazel Yang Ashland, KY | Endocrinology | 61 | 29 | $26K |
| Arif A Somjee Ashland, MS | Internal Medicine | 37 | 15 | $26K |
| Matthew S Leone Newburgh, NY | Endocrinology | 89 | 34 | $25K |
| Mohammad Daoud Owosso, MI | Endocrinology | 44 | 17 | $25K |
| Saleh Khaddash Clifton, NJ | Endocrinology | 98 | 35 | $25K |
| Juan D Palacios Merchan Edinburg, TX | Endocrinology | 95 | 41 | $25K |
| Stacy L Congdon Johnson City, NY | Nurse Practitioner | 65 | 31 | $25K |
| Dale A Hanson Flint, MI | Family Practice | 38 | 15 | $24K |
| Maurice Alazar Cleburne, TX | Internal Medicine | 51 | 20 | $24K |
| Imran A Patel Burleson, TX | Endocrinology | 51 | 33 | $24K |
| Hugo M Toro Katy, TX | Internal Medicine | 81 | 36 | $24K |
| Nduche C Onyeaso Fayetteville, NC | Endocrinology | 118 | 51 | $24K |
| Natalie K Brown Hot Springs, AR | Nurse Practitioner | 78 | 25 | $23K |
| Spending |
|---|
| Novo Nordisk NVO | 559,470 | $121.3M |